A very interesting testimonial and video featuring a CHF affected person demonstrating remarkable recovery during a clinical trial using Mesoblast MPC's at a 150m dose. Unlikely to be placebo. Silviu and the entire Board will be most encouraged by this.
Its my understanding that success with CHF will give great confidence in the many other conditions that Mesoblast will be able to address.
On a relative basis it's also my understanding that CHF has been seen as the ultimate test of the functionality of our cells.
Testimonial MPC-150-IM clinical trial phase 2
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.53 |
Change
0.010(0.66%) |
Mkt cap ! $1.712B | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.54 | $1.48 | $5.153M | 3.417M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2371 | $1.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 2383 | 2 |
View Market Depth
| Last trade - 15.59pm 13/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |